PTO/SB/08a (02-18)
`Doc code: IDS
`Approved for use through 11/30/2020. OMS 0651-0031
`en
`.
`'
`~:
`:
`.
`eatinn:
`U.S. Patent and Trademark Office: US. DEPARTMENT OF COMMERCE
`Doc description: Information Disclosure Statement (IDS) Filed
`Under the Paperwork Reduction Act of 1995, no persons are required io respond to a collection of information unless it contains a valid OMB control number.
`
`Application Number
`
`17858291
`
`Examiner! Cite
`ite
`initial
`iNo
`
`Patent Number
`
`Kind
`Code!
`
`Issue Date
`
`Name of Patentee or Applicant PagesColumns,Lines where
`.
`Relevant Passages or Relevant
`of ced Document
`:
`i;
`Figures Appear
`
`U.S.PATENTS
`
`4994177
`
`4991-02-19
`
`Earl M. Bogar Jr.
`
`column 3, line 19 - column 4, line 12:
`figures 7,2
`
`
`
`10383315 B2|2019-08-20|John M. Lipscomb column4, line 73 - column 11, line
`
`14; figures 1-72
`
`if you wish to add additional U.S. Patent citation information please click the Add button.
`
`U.S.PATENT APPLICATION PUBLICATIONS
`
`Pages,Columns,Lines where
`
`| Publication Kind|Publication Name of Patentee or Applicant
`
`
`Examiner!
`Cite No
`Relevant Passages or Relevant
`initial*
`|
`of cited Document
`i Number
`Code!) Date
`Figures Appear
`
`20070023338
`
`2007-02-01
`
`
`
`
`Daniel A. Newman
`
`(Not for submission under 37 CFR 1.99) Beminewamefd
`
`
`
`
`
`
`
`
`
`
`paragraphs [0003], [0024] - [0023],
`{0031}, [0032]; figures 1-5
`
`
`
`| 20170362092
`
`Al
`
`2017-12-21
`
`Chrisicpher E. Mainini, et al.
`
`paragraphs [6089] - {0093}; fiqure 9
`
`
`if you wish to add additional U.S. Published Application citation information please click the Add button.
`FOREIGN PATENT DOCUMENTS
`
`
`Pages,Columns,Lines
`Name of Patentee or
`
`Examiner Cite | Foreign Document | Kind|Publication| Country
`
`i where Relevant
`
`
`
`Applicant of cited
`i Code4! Date
`initial*
`{No
`| Numberé
`i Code?|
`Passages or Relevant
`Document
`
`
`
`i Figures Appear
`
`
`
`
`
`
`
`EFS Web 2.1.18
`
`

`

`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`ssi
`
`Ast Unit nn
`
`if you wish to add additional Foreign Patent Documentcitation information please click the Add button
`
`NON-PATENT LITERATURE DOCUMENTS
`
`—
`i TS
`
`| lactude name of the author (in CAPITAL LETTERS), title of the article @vhen appropriate), title of the item
`|...
`_
`Examiner] Cite |
`oo
`.
`.
`:
`i
`| (book, magazine, journal, serial, symposium, catalog, etc), date, pages{s), volurne-issue number(s),
`initials*
`i publisher, city and/or country where published.
`
`(Not for submission under 37 CFR 1.99} Esaminerame[CS
`| No European Search Report from Corresponding European Application Ne. 22183029.2, dated January 3, 2023, 7 pages.t|
`English language translation is attached.
`
`if you wish to add additional non-patent literature document citation information please click the Add button
`
`EXAMINER SIGNATURE
`
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Drawline through a
`citation if not in conformance and not considered.
`include copy of this form with next communication to applicant.
`
`° Enter office that issued the document, by the two-letter code (WIPO
`1 See Kind Codes of USPTO Patent Documenis at www. USPTO.GOV or MPEP 901.04.
`Standard ST.3).
`° For Japanese patent documents, the indication of the year of the reign of the Ermperor must precede the serial number of the patent document.
`* Kind of document by the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible.
`5 Applicant is to place a check mark here iff
`
`EFS Web 2.1.18
`
`

`

`INFORMATION DISCLOSURE
`
`ist Named inventor
`
`STATEMENT BY APPLICANT aauatS™~=é~dSi‘NO!#”#”!”O
`(Not for submission under 37 CFR 1.99}a
`
`Please see 37 CFR 1.97 and 1.98 to make the appropriate selection(s):
`
`CERTIFICATION STATEMENT
`
`[|
`
`That each item of information contained in the information disclosure statement was first cited in any communication
`from a foreign patent office in a counterpart foreign application not more than three months prior to the filing of the
`information disclosure statement. See 37 CFR 1.97(e)(4).
`
`That no item of information contained in the information disclosure siatement was ciied in a communication from a
`foreign patient office in a counterpart foreign application, and, to the knowledge of the person signing the certification
`after making reasonable inquiry, no item of information contained in the information disclosure statement was known to
`any individual designated in 37 CFR 14.56(c} more than three months prior to the filling of the information disclosure
`statement. See 37 CFR 1.97(e)(2).
`
`VA 22313-1480.
`
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the
`public whichis to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR
`1.14. This collection is estimated to take 1 hour ic complete, including gathering, preparing and submitting the completed
`application form to ihe USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you
`require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief information Officer, U.S.
`Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. BO NOT SEND
`FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria,
`
`See attached certification statement.
`
`The fee set forth in 37 CFR 1.17 (p) has been submitted herewith.
`
`A certification statement is not submitied herewith.
`
`SIGNATURE
`A signature of the applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d) for the
`form of the signature.
`
`Name/Print
`
`Registration Number
`
`34512
`
`EFS Web 2.1.18
`
`

`

`Privacy Act Statement
`
`|
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission ofthe
`attached form related to a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised |
`that:
`(1) the general authority for the collection of this information is 35 U.S.C. 2(b){2); (2) furnishing of the information solicited |
`is voluntary; and @) the principal purpose for whichthe information is used by the U.S. Patent and Trademark Office is to
`|
`process and/or examine your submission related to a patent application or patent.
`If you do not furnish the requested
`information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`resull in termination of proceedings or abandonmentof the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`The information on this form will be treated confidentiaily to the extent allowed under the Freedom of Information Act|
`(5 U.S.C. 552) and the Privacy Act ( U.S.C. 552a). Records fromthis system of records may be disclosed to the
`Department of Justice to determine whether the Freedom of information Act requires disclosure of these record s.
`
`1.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidenceto a
`court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement
`negotiations.
`
`A record in this system of records may be disciosed, as a routine use, to a Member of Congress submitting a
`request involving an individual, io whom the record pertains, when the individual has requested assistance from the
`Member with respect to the subject matter of the record.
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for |
`the information in order to perform a contract. Recipients of information shall be required to comply with the
`|
`requiremenis of the Privacy Act of 1974, as amended, pursuantio 5 U.S.C. 552a(m).
`
`|
`A record related to an international Application filed under the Patent Cooperation Trealy in this system of records
`may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant|
`io the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of
`National Security review (35 0.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or
`his/her designee, during an inspection of records conducted by GSAaspart of that agency's responsibility to
`recommend improvements in records management practices and programs, under authority of 44 U.S.C. 2904 and
`2906. Such disclosure shail be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant (.¢e., GSA or Commerce) directive. Such disclosure shall not be used to make
`determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record
`may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record was filed in
`an application which became abandoned or in which the proceedings were terminated and which application is
`referenced byeither a published application, an application open to public inspections or an issued patent.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency, ifthe USPTO becomes aware of a violation or potential violation of law or regulation.
`
`EFS Web 2.1.18
`
`